SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950123-98-007026
Filing Date
1998-07-31
Accepted
1998-07-31 00:00:00
Documents
1
Period of Report
1998-06-30
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 NYMOX PHARMACEUTICAL CORPORATION 6-K 25850
  Complete submission text file 0000950123-98-007026.txt   27303
Mailing Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA, H9S 1B1 A8
Business Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA H9S 1B1 A8 5146363122
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 98675029
SIC: 2835 In Vitro & In Vivo Diagnostic Substances